Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for Parkinson's disease: Why it doesn't work every time.

Timothy J Collier1, Caryl E Sortwell1, Natosha M Mercado1

  • 1Translational Science and Molecular Medicine, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA, and Hauenstein Neuroscience Center, Mercy Health/St. Mary's, Grand Rapids, Michigan, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|June 25, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement Dysregulation During the Early Phases of Synucleinopathy.

bioRxiv : the preprint server for biology·2026
Same author

Disease-modifying, multidimensional efficacy of putaminal Ca<sub>V</sub>1.3-shRNA gene therapy in aged parkinsonism male and female macaques.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions.

Muscle & nerve·2025
Same author

Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor function.

Frontiers in neuroscience·2025
Same author

Advancing age and sex modulate antidyskinetic efficacy of striatal Ca<sub>V</sub>1.3 gene therapy in a rat model of Parkinson's disease.

Neurobiology of aging·2025
Same author

Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS.

Molecular therapy. Nucleic acids·2024

Cell replacement therapy for Parkinson's disease (PD) shows variable results. Preclinical studies suggest that the aged brain's impaired striatum, not just neuron survival, limits therapeutic recovery in PD.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Cell replacement therapy using dopamine neuron transplantation is a potential treatment for advanced Parkinson's disease (PD).
  • Clinical outcomes have been inconsistent, with some patients showing benefit and others experiencing no improvement despite successful graft survival.

Purpose of the Study:

  • To investigate the reasons for variable therapeutic responses in cell replacement therapy for PD.
  • To evaluate the role of the host striatum's integrity in functional recovery after dopamine neuron transplantation.

Main Methods:

  • Preclinical studies were conducted using aged rats as a model.
  • Fetal dopamine neurons were transplanted, and graft survival, striatal reinnervation, synaptic connections, and behavioral recovery were assessed.
Keywords:
Parkinson's diseaseagingcell transplantationdopaminestriatum

Related Experiment Videos

Main Results:

  • Transplanted dopamine neurons survived well and densely reinnervated the striatum.
  • However, synaptic connections between the graft and host were reduced, and behavioral recovery was impaired.
  • These findings suggest that the host environment significantly impacts functional outcomes.

Conclusions:

  • The variability in therapeutic response to dopamine neuron grafts may be more dependent on the integrity and repair capacity of the aged, dopamine-depleted striatum than on the viability of the transplanted neurons.
  • Successful cell replacement therapy requires a receptive host environment for optimal functional integration and recovery.